Bioregenx (BRGX) Gross Margin (2023 - 2026)
Bioregenx's quarterly Gross Margin came in at 81.72% in Q1 2026, up 291.0% year-on-year from 20.9% in Q1 2025, and down 1.13% quarter-over-quarter from 82.66% in Q4 2025.
Bioregenx has reported Gross Margin for 4 years, with the latest figure at 81.72% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 291.0% year-over-year to 81.72%; the trailing twelve-month figure through Mar 2026 stood at 81.9% (up 902.0% YoY), and the FY2025 full-year result was 81.08%, up 1021.0% from the prior year.
- Gross Margin for Q1 2026 stood at 81.72%, down from 82.66% in the prior quarter.
- The five-year high for Gross Margin was 83.98% in Q3 2025, with the low at 55.76% in Q4 2023.
- Average Gross Margin over 4 years is 73.77%, with a median of 71.89% recorded in 2023.
- Year-over-year, Gross Margin plunged 529 bps in 2024 and soared 1502 bps in 2025.
- Tracing BRGX's Gross Margin over 4 years: stood at 55.76% in 2023, then grew by 26 bps to 70.09% in 2024, then grew by 18 bps to 82.66% in 2025, then fell by 1 bps to 81.72% in 2026.
- The last three Gross Margin figures came in at 81.72% (Q1 2026), 82.66% (Q4 2025), and 83.98% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 74.46% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 13.34% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 72.27% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 84.60% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 86.65% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 85.40% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 70.39% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 98.65% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 45.30% |
| 10 | Bioregenx | - | - | 348,288.00 | 81.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.72% |
| Dec 31, 2025 | 82.66% |
| Sep 30, 2025 | 83.98% |
| Jun 30, 2025 | 79.03% |
| Mar 31, 2025 | 78.82% |
| Dec 31, 2024 | 70.09% |
| Sep 30, 2024 | 80.81% |
| Jun 30, 2024 | 64.01% |
| Mar 31, 2024 | 69.90% |
| Dec 31, 2023 | 55.76% |
| Sep 30, 2023 | 71.89% |
| Jun 30, 2023 | 67.78% |
| Mar 31, 2023 | 71.02% |